Valuation: Amgen Inc.

Market Cap 239B 205B 192B 176B 330B 22,859B 336B 2,260B 885B 11,464B 898B 878B 37,905B P/E 2026 *
28x
P/E 2027 * 25x
Enterprise Value 281B 241B 225B 206B 388B 26,824B 394B 2,652B 1,039B 13,453B 1,054B 1,031B 44,481B EV / Sales 2026 *
7.21x
EV / Sales 2027 * 6.84x
Free-Float
99.77%
Yield 2026 *
2.28%
Yield 2027 * 2.41%
1 day-1.71%
1 week+4.15%
Current month+12.99%
1 month+19.50%
3 months+31.25%
6 months+16.13%
Current year+32.96%
1 week 410.4
Extreme 410.4
443.2
1 month 359.21
Extreme 359.212
443.2
Current year 318.21
Extreme 318.21
443.2
1 year 269.77
Extreme 269.77
443.2
3 years 248.38
Extreme 248.38
443.2
5 years 198.64
Extreme 198.64
443.2
10 years 133.64
Extreme 133.64
443.2
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
8/13/26 Fiscal year

Executive/Senior Manager

3,756 0.0007%
8/7/26 Free

Director

85 0.0000%
8/7/26 Free

Controller/Auditor

730 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.66%+4.15%+46.80%+66.94% 239B
-1.33%+4.33%+78.81%+129.32% 1,141B
-0.75%+3.32%+51.41%+61.80% 659B
-0.26%+5.65%+26.70%+76.48% 470B
+0.53%+1.90%+40.70%+45.18% 366B
-0.65%+1.87%+23.15%+40.07% 302B
-0.74%+1.93%-0.35%+11.80% 254B
-0.78%-0.22%-13.89%-52.81% 207B
-2.14%+4.88%+22.02%+90.78% 183B
-1.58%+3.41%+9.20%-25.11% 161B
Average -0.95%+3.93%+28.46%+44.45% 398.19B
Weighted average by Cap. -0.90%+4.23%+43.19%+68.70%

Financials

2026 *2027 *
Net sales 38.94B 33.4B 31.19B 28.62B 53.81B 3,722B 54.7B 368B 144B 1,867B 146B 143B 6,172B 40.2B 34.48B 32.2B 29.54B 55.55B 3,842B 56.46B 380B 149B 1,927B 151B 148B 6,371B
Net income 8.6B 7.37B 6.89B 6.32B 11.88B 822B 12.08B 81.26B 31.82B 412B 32.28B 31.58B 1,363B 9.39B 8.06B 7.52B 6.9B 12.98B 898B 13.2B 88.78B 34.77B 450B 35.27B 34.5B 1,489B
Net Debt 41.49B 35.59B 33.23B 30.49B 57.33B 3,965B 58.28B 392B 154B 1,989B 156B 152B 6,575B 35.83B 30.73B 28.7B 26.33B 49.51B 3,424B 50.33B 339B 133B 1,717B 135B 132B 5,679B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-08-20 $435.30 -1.60% 282,095
26-08-19 $442.36 +4.02% 2,543,982
26-08-18 $425.28 +1.41% 2,591,635
26-08-17 $419.38 +1.00% 2,880,643
26-08-14 $415.21 -0.63% 2,036,768
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
442.36USD
Average target price
388.48USD
Spread / Average Target
-12.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock